Does gliotoxin disrupt redox balance and immune regulation, while mycophenolic acid suppresses lymphocyte and antibody responses?

Gliotoxin and mycophenolic acid both affect immune function, but through distinct mechanisms and with very different clinical contexts. The evidence strongly supports each part of the claim.

Gliotoxin: redox and immune effects

• Gliotoxin’s disulfide bridge can react with cellular thiols, deplete glutathione, undergo redox cycling, and promote reactive-oxygen-species formation. In LPS-stimulated murine dendritic cells, total glutathione fell in a concentration-dependent manner.
• This thiol disturbance has functional immune consequences: replenishing thiols with N-acetylcysteine or glutathione ethyl ester partially restored gliotoxin-suppressed IL-12 secretion.
• Across immune-cell models, gliotoxin alters cytokine production and NF-κB signaling, reduces phagocytosis and neutrophil ROS output, and can reduce lymphocyte metabolic activity. In macrophages, 0.3–3 μM induced DNA fragmentation and apoptosis within 5 hours.
• Its effects are context-dependent: redox disruption may appear as oxidant injury in some cells but impaired NADPH-oxidase-derived ROS in neutrophils. Most supporting data are experimental, with limited direct human exposure–function linkage.

Mycophenolic acid: lymphocyte and antibody suppression

• Mycophenolic acid reversibly inhibits IMPDH, particularly IMPDH2 expressed in activated lymphocytes, restricting de novo guanosine-nucleotide synthesis needed for DNA replication and cell-cycle progression. Guanosine reversibility supports this as the causal mechanism.
• It suppresses proliferative expansion of both T and B cells, including IL-2/IL-15-driven T-cell expansion, while relatively preserving early receptor signaling.
• In primary human B cells, it inhibits activation, proliferation, plasma-cell differentiation, and immunoglobulin production. Existing plasma cells are relatively less susceptible, so the main effect is impaired generation of new antibody responses.
• In transplant recipients, MPA derivatives were associated with greater humoral vaccine-response failure (OR 5.38, 95% CI 3.76–7.70).

Bottom line

• Gliotoxin disrupts redox-sensitive immune functions, whereas mycophenolic acid produces a well-established, clinically meaningful suppression of lymphocyte proliferation and new antibody formation.